Nine teams of cyclists will relay nearly 3,000 miles across the United States this September. Their goal: $1 million for cancer research. Watch our U.S. colleagues’ epic #C2C4C journey to raise funds for the V Foundation and learn how you can join their efforts: cancerbikeride.org
Bristol Myers Squibb
Pharmaceutical Manufacturing
Lawrence Township, NJ 1,415,499 followers
About us
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
- Website
-
http://www.bms.com
External link for Bristol Myers Squibb
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Lawrence Township, NJ
- Type
- Public Company
- Specialties
- biotechnology, innovation, great place to work, pharmaceuticals, research and development, and healthcare
Locations
Employees at Bristol Myers Squibb
-
Bill Trebasky
Biopharmaceuticals Operations Executive
-
Mark Kaplan
Senior Director Translational Oncology
-
Lisa Filaferro, MBA, PHR
-
Lakshman Nagesh Yerramalla
Transformations Strategist, Sr. PMO Leader - Expert in envisioning and driving transformational initiatives, Building high-performance PMO
Updates
-
Together, the three pillars of our research framework and differentiated platforms, targeted #ProteinDegradation, #CellTherapy and radiopharmaceutical therapeutics (RPTs), enable our teams around the world to deliver transformative and high-quality medicines with an increased probability of success. Our Head of Research, Robert Plenge, outlines the strategy and his vision for what’s next in R&D: https://bit.ly/3Vmh1Y1
-
Since 2014, hundreds of our colleagues from Europe, the United States, Japan, and Latin America have participated in #C2C4C, an epic bike ride that’s raised over $16 million for cancer research. Meet some of the participants and see how you can join their efforts to raise money for cancer research with patients top of mind: cancerbikeride.org
-
Partnerships play a critical role in our innovation strategy. At #BIO2024, we’re discussing the power of our collaborations in delivering innovative medicines that help patients prevail over serious diseases. Learn more about partnering with us: https://bit.ly/3x81ZvN
-
A new Nature Portfolio Nature Reviews Drug Discovery article led by Francisco Ramírez-Valle, MD, PhD, FAAD, senior vice president and head of our Immunology and Cardiovascular Thematic Research Center, explains how our three-step sequential #immunotherapy research framework is designed to rebalance the immune system in patients living with immune-mediated diseases, like #lupus and #SystemicSclerosis. Learn more about our research: https://lnkd.in/eucmyv2J
-
Stacey Kennedy-Conner moderated a group of expert panelists during a recent webinar hosted by Lupus Therapeutics, an affiliate of the Lupus Research Alliance and sponsored by BMS. The authentic and powerful discussions highlighted the challenges lupus patients face today and showcased the hope that research in #CARTcelltherapy offers. This research is a key focus of BMS, as we leverage our experience and expertise in #immunology and #celltherapy to explore how this innovative technology might help to one day meet the needs of patients living with autoimmune diseases like #lupus.
-
Discover our Inside the Science platform, providing healthcare professionals with in-depth disease education on oncology, hematology and cell therapy. Register at insidethescience.com for informative medical videos, including the latest on cell therapy.
Stay updated by joining us at #ASCO24
insidethescience.com
-
We are dedicated to evaluating dual #immunotherapy combinations that have the potential to improve outcomes for patients with advanced #HCC. Liver cancer is the third leading cause of cancer mortality worldwide. #ASCO24 https://bit.ly/4aSCLPQ
-
Our Board Chair and CEO Chris Boerner, PRIDE Alliance leader Frank Sperber, and Alliance members kicked off #PrideMonth today with the annual flag raising to celebrate our LGTBQIA+ colleagues, patients, and partners around the world. Learn more about the Alliance and how they advance our culture of inclusion where everyone feels like they belong: https://lnkd.in/e_HkKsz7
-
At Bristol Myers Squibb, Business Development, paired with R&D and enabled by strong global capabilities, is core to driving our innovation engine and future growth. Follow along during #BIO2024 in San Diego to learn why BMS is a partner of choice in biotech. https://bit.ly/4aOVQCD
Affiliated pages
Similar pages
Browse jobs
Stock
BMY
NYSE
20 minutes delay
$42.57
1.09 (2.628%)
- Open
- 41.4
- Low
- 41.36
- High
- 42.72
Data from Refinitiv
See more info on